This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jessica Byerly: Inventor in PTK6-Targeted Compounds
Introduction
Jessica Byerly is an inventor associated with the Icahn School of Medicine at Mount Sinai in New York, NY, US. Her patent work concerns compounds designed to degrade or disrupt protein tyrosine kinase 6 (PTK6).
Latest Patents
Byerly is named on 1 patent: “Protein tyrosine kinase 6 (PTK6) degradation / disruption compounds and methods of use.” The patent describes compounds comprising a PTK6 ligand, a degradation or disruption tag, and a linker. It also outlines methods for using these compounds to treat diseases mediated by PTK6.
Career Highlights
Byerly’s listed patent reflects research into targeted approaches for modulating PTK6, a protein tyrosine kinase. The disclosed compounds are intended to promote PTK6 degradation or disruption and may support the development of treatments for PTK6-mediated diseases.
Collaborations
Byerly’s listed coworkers include Hanna Irie and Jian Jin. The patent’s research is associated with the Icahn School of Medicine at Mount Sinai.
Conclusion
Jessica Byerly’s patent highlights an approach to targeting PTK6 through compounds designed for its degradation or disruption, with potential applications in treating PTK6-mediated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile